Publicacións nas que colabora con Vicente Bertomeu González (18)

2024

  1. Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes

    Medicina Clinica

2022

  1. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

2021

  1. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  2. Managing NSTEMI in older patients

    The Lancet

  3. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  4. Mortality associated with cardiovascular disease in patients with COVID-19

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 30-38

  5. New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 494-501

2020

  1. Estimation of the major cardiovascular events prevention with Inclisiran

    Atherosclerosis, Vol. 313, pp. 76-80

  2. Long-term bleeding risk vs. mortality risk in acute coronary syndrome patients according to the 2019 ARC-HBR definition

    Thrombosis Research

2019

  1. Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome

    International Journal of Cardiology, Vol. 276, pp. 20-25

2018

  1. Letter by cordero et al regarding article, "prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (Improved reduction of outcomes: Vytorin efficacy international trial)"

    Circulation

  2. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication

    International Journal of Cardiology, Vol. 270, pp. 36-41

2016

  1. Evaluación comparativa de cuatro puntuaciones de riesgo para predecir la mortalidad de pacientes con desfibrilador automático implantable en prevención primaria

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1033-1041

  2. Prevención primaria de muerte súbita en pacientes con miocardiopatía valvular

    Revista Espanola de Cardiologia, Vol. 69, Núm. 3, pp. 272-278

  3. Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: Results of a Spanish multicentre study

    Europace, Vol. 18, Núm. 8, pp. 1203-1210

2013

  1. Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 103-109

2011

  1. Anticoagulation prescription in atrial fibrillation

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 10, pp. 1473-1479

  2. Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular

    Revista Espanola de Cardiologia, Vol. 64, Núm. 8, pp. 649-653